Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effectiveness in adults, of four
different strengths of resiquimod gel applied to common wart(s) three times a week for twelve
weeks.
A second purpose is to evaluate the safety of the drug.